期刊文献+

黏膜疫苗佐剂研究进展 被引量:2

Recent advances in mucosal adjuvant
下载PDF
导出
摘要 黏膜疫苗在抵御多种病源微生物感染方面有着巨大的潜力和优势。在发展黏膜疫苗过程中最大的障碍是寻找安全、高效的疫苗佐剂和递药系统。最近,基于脱毒细菌毒素衍生物和病原体相关模式分子的黏膜佐剂研究有了较大的进步,细胞因子佐剂和多种疫苗递药系统也取得了很多进展。然而,黏膜疫苗佐剂的安全性和有效性还存在很多问题,目前适合人类使用的黏膜疫苗并不多。本文将目前黏膜疫苗佐剂的研究进展做一综述。 Mucosal vaccines have great advantages in defending various pathogens.One major obstacle in developing mucosal vaccine is production of some safe and efficient adjuvant and(or) delivery system.Promising advances have recently been made in the design of more efficient mucosal adjuvants based on detoxified bacterial toxin derivatives or the ligands of Toll like receptors,and perhaps even more striking progress has been done in the use of cytokines and virus-like particles.However,mucosal vaccine for human use is very limited because of their adverse reactions in the vaccinees.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第z1期97-100,104,共5页 Immunological Journal
关键词 黏膜 佐剂 疫苗 Mucosal Adjuvant Vaccine
  • 相关文献

参考文献20

  • 1[1]Murphy TV,Gargiullo PM,Massoudi MS,et al.Intussusception among infants given an oral rotavirus vaccine[ J ].N Engl J Med,2001,344(8):564-572. 被引量:1
  • 2[2]de Haan L.Hirst TR.Cholera toxin and related enterotoxins:a cell biological and immunological perspective[J].J Nat Toxins,2000,9(3):281-297. 被引量:1
  • 3[3]Gagliardi MC,Sallusto F,Marinaro M,et al.Effects of the adjuvant cholera toxin on dendritic cells:stimulatory and inhibitory signals that resuh in the amplification ofimmune responses[J].Int J Med Microbiol,2002,291(6/7):571 -575. 被引量:1
  • 4[4]Eriksson K,Fredriksson M,Nordstr(o)m I,et al.Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1/Th2 development[ J].Infect Immun,2003,71 (4):1 740-1 747. 被引量:1
  • 5[5]Haan L,Verweij WR,Holtrop M,et al.Nasal or intramuscular immunizatiou of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA-or IgG-mediated protective mucosal immunity[ J].Vaccine,2001,19 (20/22):2 898-2 907. 被引量:1
  • 6[6]Lomada D,Gambhira R,Nehete PN,et al.A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens[J].Vaccine,2004,23(4):555-565. 被引量:1
  • 7[7]De Filette M,Ramne A,Birkett A,et al.The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection[J].Vaccine.2006,24(5):544-551. 被引量:1
  • 8[8]Sanchez J,Wallerstrom G,Fredriksson M,et al.Detoxification of cholera toxin without removal of its immunoadjuvanticity by the addition of (STa-related) peptides to the catalytic subunit.A potential new strategy to generate immunostimulants for vaccination[ J ].J Biol Chem,2002,277 (36):33 369-33 377. 被引量:1
  • 9[9]Gallichan WS,Woolstencroft RN,Guarasci T,et al.Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract[J].J Immunol,2001,166 (5):3 451-3 457. 被引量:1
  • 10[10]Harandi AM,Eriksson K,Holmgren J.A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection[ J].J Virol,2003,77(2):953-962. 被引量:1

同被引文献2

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部